PCM

Pentwater Capital Management’s Sutro Biopharma STRO Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-450,000	Closed	-$1.93M	–	84
2023 Q4	$1.93M	Buy	450,000 +20,000	+5%	+$85.8K	0.02%	50
2023 Q3	$1.49M	Buy	430,000 +30,000	+8%	+$104K	0.01%	53
2023 Q2	$1.86M	Buy	400,000 +145,000	+57%	+$674K	0.01%	59
2023 Q1	$1.18M	Buy	255,000 +30,000	+13%	+$139K	0.01%	71
2022 Q4	$1.82M	Sell	225,000 -135,000	-38%	-$1.09M	0.03%	54
2022 Q3	$2M	Sell	360,000 -20,000	-5%	-$111K	0.02%	71
2022 Q2	$1.98M	Buy	380,000 +130,000	+52%	+$677K	0.02%	87
2022 Q1	$2.06M	Buy	250,000 +20,000	+9%	+$164K	0.02%	78
2021 Q4	$3.42M	Buy	230,000 +20,000	+10%	+$298K	0.04%	77
2021 Q3	$3.97M	Hold	210,000	–	–	0.04%	79
2021 Q2	$3.9M	Buy	210,000 +25,499	+14%	+$474K	0.03%	84
2021 Q1	$4.2M	Sell	184,501 -100,000	-35%	-$2.28M	0.04%	86
2020 Q4	$6.18M	Sell	284,501 -90,499	-24%	-$1.96M	0.07%	48
2020 Q3	$3.77M	Sell	375,000 -7,026	-2%	-$70.6K	0.05%	69
2020 Q2	$2.97M	Buy	382,026 +307,641	+414%	+$2.39M	0.05%	47
2020 Q1	$759K	Sell	74,385 -5,507	-7%	-$56.2K	0.01%	67
2019 Q4	$879K	Sell	79,892 -9,189	-10%	-$101K	0.01%	66
2019 Q3	$810K	Sell	89,081 -10,919	-11%	-$99.3K	0.01%	72
2019 Q2	$1.14M	Sell	100,000 -27,005	-21%	-$307K	0.01%	80
2019 Q1	$1.45M	Buy	127,005 +25,197	+25%	+$287K	0.02%	72
2018 Q4	$918K	Buy	101,808 +31,808	+45%	+$287K	0.01%	78
2018 Q3	$1.05M	Buy	+70,000	New	+$1.05M	0.01%	71